Michael J Roy

13PUBLICATIONS
64CO-AUTHORS
Haematological tumoursProteomics and intermolecular interactions (excl. medical proteomics)Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 19, 2026
Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors.

Nishma Gupta, Nicole Trainor, Mona Radwan

|Sep 29, 2025
Frustration in the protein-protein interface plays a central role in the cooperativity of PROTAC ternary complexes.

Ning Ma, Supriyo Bhattacharya, Sanychen Muk

|Jul 15, 2025
Accurate PROTAC-targeted degradation prediction with DegradeMaster.

Jie Liu, Michael J Roy, Luke Isbel

|Dec 13, 2023
Sequence differences between BAX and BAK core domains manifest as differences in their interactions with lipids.

Michelle S Miller, Angus D Cowan, Jason M Brouwer

|Jun 19, 2023
Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling.

Michael J Roy, Minglyanna G Surudoi, Ashleigh Kropp

|Oct 10, 2022
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo.

Christiane Kofink, Nicole Trainor, Barbara Mair

Pageof 3

Frequent Collaborators

4 joint publications

William Farnaby

4 joint publications

Alessio Ciulli

4 joint publications

Isabelle S Lucet

3 joint publications

Nicole Trainor